H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia

Masahiro Kawahara, Ashley Pandolfi, Boris Bartholdy, Laura Barreyro, Britta Will, Michael Roth, Ujunwa C. Okoye-Okafor, Tihomira I. Todorova, Maria Figueroa, Ari Melnick, Constantine S. Mitsiades, Ulrich Steidl

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Homeobox domain-containing transcription factors are important regulators of hematopoiesis. Here, we report that increased levels of nonclustered H2.0-like homeobox (HLX) lead to loss of functional hematopoietic stem cells and formation of aberrant progenitors with unlimited serial clonogenicity and blocked differentiation. Inhibition of HLX reduces proliferation and clonogenicity of leukemia cells, overcomes the differentiation block, and leads to prolonged survival. HLX regulates a transcriptional program, including PAK1 and BTG1, that controls cellular differentiation and proliferation. HLX is overexpressed in 87% of patients with acute myeloid leukemia (AML) and independently correlates with inferior overall survival (n = 601, p = 2.3 × 10 -6). Our study identifies HLX as a key regulator in immature hematopoietic and leukemia cells and as a prognostic marker and therapeutic target in AML.

Original languageEnglish (US)
Pages (from-to)194-208
Number of pages15
JournalCancer Cell
Volume22
Issue number2
DOIs
StatePublished - Aug 14 2012
Externally publishedYes

Fingerprint

Homeobox Genes
Hematopoiesis
Acute Myeloid Leukemia
Leukemia
Survival
Hematopoietic Stem Cells
Cell Differentiation
Transcription Factors
Cell Proliferation

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Kawahara, M., Pandolfi, A., Bartholdy, B., Barreyro, L., Will, B., Roth, M., ... Steidl, U. (2012). H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia. Cancer Cell, 22(2), 194-208. https://doi.org/10.1016/j.ccr.2012.06.027

H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia. / Kawahara, Masahiro; Pandolfi, Ashley; Bartholdy, Boris; Barreyro, Laura; Will, Britta; Roth, Michael; Okoye-Okafor, Ujunwa C.; Todorova, Tihomira I.; Figueroa, Maria; Melnick, Ari; Mitsiades, Constantine S.; Steidl, Ulrich.

In: Cancer Cell, Vol. 22, No. 2, 14.08.2012, p. 194-208.

Research output: Contribution to journalArticle

Kawahara, M, Pandolfi, A, Bartholdy, B, Barreyro, L, Will, B, Roth, M, Okoye-Okafor, UC, Todorova, TI, Figueroa, M, Melnick, A, Mitsiades, CS & Steidl, U 2012, 'H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia', Cancer Cell, vol. 22, no. 2, pp. 194-208. https://doi.org/10.1016/j.ccr.2012.06.027
Kawahara M, Pandolfi A, Bartholdy B, Barreyro L, Will B, Roth M et al. H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia. Cancer Cell. 2012 Aug 14;22(2):194-208. https://doi.org/10.1016/j.ccr.2012.06.027
Kawahara, Masahiro ; Pandolfi, Ashley ; Bartholdy, Boris ; Barreyro, Laura ; Will, Britta ; Roth, Michael ; Okoye-Okafor, Ujunwa C. ; Todorova, Tihomira I. ; Figueroa, Maria ; Melnick, Ari ; Mitsiades, Constantine S. ; Steidl, Ulrich. / H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia. In: Cancer Cell. 2012 ; Vol. 22, No. 2. pp. 194-208.
@article{0d85f6fae8234c91bc6a08420c927c68,
title = "H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia",
abstract = "Homeobox domain-containing transcription factors are important regulators of hematopoiesis. Here, we report that increased levels of nonclustered H2.0-like homeobox (HLX) lead to loss of functional hematopoietic stem cells and formation of aberrant progenitors with unlimited serial clonogenicity and blocked differentiation. Inhibition of HLX reduces proliferation and clonogenicity of leukemia cells, overcomes the differentiation block, and leads to prolonged survival. HLX regulates a transcriptional program, including PAK1 and BTG1, that controls cellular differentiation and proliferation. HLX is overexpressed in 87{\%} of patients with acute myeloid leukemia (AML) and independently correlates with inferior overall survival (n = 601, p = 2.3 × 10 -6). Our study identifies HLX as a key regulator in immature hematopoietic and leukemia cells and as a prognostic marker and therapeutic target in AML.",
author = "Masahiro Kawahara and Ashley Pandolfi and Boris Bartholdy and Laura Barreyro and Britta Will and Michael Roth and Okoye-Okafor, {Ujunwa C.} and Todorova, {Tihomira I.} and Maria Figueroa and Ari Melnick and Mitsiades, {Constantine S.} and Ulrich Steidl",
year = "2012",
month = "8",
day = "14",
doi = "10.1016/j.ccr.2012.06.027",
language = "English (US)",
volume = "22",
pages = "194--208",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia

AU - Kawahara, Masahiro

AU - Pandolfi, Ashley

AU - Bartholdy, Boris

AU - Barreyro, Laura

AU - Will, Britta

AU - Roth, Michael

AU - Okoye-Okafor, Ujunwa C.

AU - Todorova, Tihomira I.

AU - Figueroa, Maria

AU - Melnick, Ari

AU - Mitsiades, Constantine S.

AU - Steidl, Ulrich

PY - 2012/8/14

Y1 - 2012/8/14

N2 - Homeobox domain-containing transcription factors are important regulators of hematopoiesis. Here, we report that increased levels of nonclustered H2.0-like homeobox (HLX) lead to loss of functional hematopoietic stem cells and formation of aberrant progenitors with unlimited serial clonogenicity and blocked differentiation. Inhibition of HLX reduces proliferation and clonogenicity of leukemia cells, overcomes the differentiation block, and leads to prolonged survival. HLX regulates a transcriptional program, including PAK1 and BTG1, that controls cellular differentiation and proliferation. HLX is overexpressed in 87% of patients with acute myeloid leukemia (AML) and independently correlates with inferior overall survival (n = 601, p = 2.3 × 10 -6). Our study identifies HLX as a key regulator in immature hematopoietic and leukemia cells and as a prognostic marker and therapeutic target in AML.

AB - Homeobox domain-containing transcription factors are important regulators of hematopoiesis. Here, we report that increased levels of nonclustered H2.0-like homeobox (HLX) lead to loss of functional hematopoietic stem cells and formation of aberrant progenitors with unlimited serial clonogenicity and blocked differentiation. Inhibition of HLX reduces proliferation and clonogenicity of leukemia cells, overcomes the differentiation block, and leads to prolonged survival. HLX regulates a transcriptional program, including PAK1 and BTG1, that controls cellular differentiation and proliferation. HLX is overexpressed in 87% of patients with acute myeloid leukemia (AML) and independently correlates with inferior overall survival (n = 601, p = 2.3 × 10 -6). Our study identifies HLX as a key regulator in immature hematopoietic and leukemia cells and as a prognostic marker and therapeutic target in AML.

UR - http://www.scopus.com/inward/record.url?scp=84865132216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865132216&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2012.06.027

DO - 10.1016/j.ccr.2012.06.027

M3 - Article

VL - 22

SP - 194

EP - 208

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 2

ER -